Group One Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Group One Trading’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-33,406	Closed	-$18K	–	6126
2019 Q4	$18K	Sell	33,406 -10,132	-23%	-$24.6K	﹤0.01%	4405
2019 Q3	$166K	Buy	+43,538	New	+$157K	﹤0.01%	3222
2019 Q2	–	Sell	-1,374	Closed	-$5.23K	–	5680
2019 Q1	$5K	Sell	1,374 -2,968	-68%	-$16.1K	﹤0.01%	4457
2018 Q4	$17K	Buy	4,342 +1,812	+72%	+$23.2K	﹤0.01%	4101
2018 Q3	$50K	Buy	2,530 +1,676	+196%	+$42.4K	﹤0.01%	3978
2018 Q2	$27K	Buy	+854	New	+$30.7K	﹤0.01%	4261

Group One Trading's MLNT Position: Q1 2020 in Review

Group One Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 33,406 shares — an estimated $18K sold.

Group One Trading first reported a position in MLNT in Q2 2018 and held it in 6 quarters. The position peaked at $166K in Q3 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Group One Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 33,406 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $18K.
Group One Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Group One Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $166K in Q3 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.